The critical role of passive permeability in designing successful drugs

L Di, P Artursson, A Avdeef, LZ Benet… - …, 2020 - Wiley Online Library
Passive permeability is a key property in drug disposition and delivery. It is critical for
gastrointestinal absorption, brain penetration, renal reabsorption, defining clearance …

Drug concentration asymmetry in tissues and plasma for small molecule–related therapeutic modalities

D Zhang, CECA Hop, G Patilea-Vrana, G Gampa… - Drug Metabolism and …, 2019 - ASPET
The well accepted “free drug hypothesis” for small-molecule drugs assumes that only the
free (unbound) drug concentration at the therapeutic target can elicit a pharmacologic effect …

In vitro and in vivo methods to assess pharmacokinetic drug– drug interactions in drug discovery and development

C Lu, L Di - Biopharmaceutics & drug disposition, 2020 - Wiley Online Library
Drug–drug interactions (DDIs) caused by the co‐administration of multiple drugs are major
safety concerns in the clinic. Several drugs have been withdrawn from the market due to …

Moving beyond binary predictions of human drug-induced liver injury (DILI) toward contrasting relative risk potential

MD Aleo, F Shah, S Allen, HA Barton… - Chemical research in …, 2019 - ACS Publications
The hepatic risk matrix (HRM) was developed and used to differentiate lead clinical and
back-up drug candidates against competitor/marketed drugs within the same …

[HTML][HTML] Interpretation of drug interaction using systemic and local tissue exposure changes

YH Choi - Pharmaceutics, 2020 - mdpi.com
Systemic exposure of a drug is generally associated with its pharmacodynamic (PD) effect
(eg, efficacy and toxicity). In this regard, the change in area under the plasma concentration …

Toward a better understanding of metabolic and pharmacokinetic characteristics of low-solubility, low-permeability natural medicines

J Yang, K Li, D He, J Gu, J Xu, J Xie… - Drug Metabolism …, 2020 - Taylor & Francis
Today, it is very challenging to develop new active pharmaceutical ingredients. Developing
good preparations of well-recognized natural medicines is certainly a practical and …

Revisiting nonlinear Bosentan pharmacokinetics by physiologically based pharmacokinetic modeling: target binding, albeit not a major contributor to nonlinearity, can …

S Koyama, K Toshimoto, W Lee, Y Aoki… - Drug Metabolism and …, 2021 - ASPET
Bosentan is a high-affinity antagonist of endothelin receptors and one of the earliest
examples for target-mediated drug disposition [a type of nonlinear pharmacokinetics (PKs) …

Physiologically based pharmacokinetic modeling of bosentan identifies the saturable hepatic uptake as a major contributor to its nonlinear pharmacokinetics

M Sato, K Toshimoto, A Tomaru, T Yoshikado… - Drug Metabolism and …, 2018 - ASPET
Bosentan is a substrate of hepatic uptake transporter organic anion–transporting
polypeptides (OATPs), and undergoes extensive hepatic metabolism by cytochrome P450 …

Transporter–enzyme interplay and the hepatic drug clearance: what have we learned so far?

RV Alluri, R Li, MVS Varma - Expert opinion on drug metabolism & …, 2020 - Taylor & Francis
Introduction: Transporters and enzymes play an important role in absorption, distribution,
clearance and elimination of drugs. Areas covered: This review provides an overview of the …

Interactions of phenethylamine‐derived psychoactive substances of the 2C‐series with human monoamine oxidases

L Wagmann, SD Brandt, A Stratford… - Drug testing and …, 2019 - Wiley Online Library
Psychoactive substances of the 2C‐series (2Cs) are phenethylamine‐derived designer
drugs that can induce psychostimulant and hallucinogenic effects. Chemically, the classic …